Ming Tan

Scopus Author ID Scopus Author ID Scopus Author ID Scopus Author ID Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

University of Texas MD Anderson Cancer Center and UTHealth at Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Texas MD Anderson Cancer Center and UTHealth at Houston

United States

PHD

Publications

Khanisyah Erza Gumilar, Yeh Chin, Ibrahim Haruna Ibrahim, Brahmana A Tjokroprawiro, Jer-Yen Yang, Ming Zhou, Natalie R Gassman, Ming Tan
Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology. Cancers 15 (21) (2023)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Ritu Arora, Jin-Hwan Kim, Ayechew Adera Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells 11 (24) (2022)
Ritu Arora, Jin-Hwan Kim, Ayechew Adera Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells 11 (24) (2022)
Ritu Arora, Jin-Hwan Kim, Ayechew Adera Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells 11 (24) (2022)
Ritu Arora, Jin-Hwan Kim, Ayechew Adera Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells 11 (24) (2022)
Ritu Arora, Jin-Hwan Kim, Ayechew Adera Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer. Cells 11 (24) (2022)
Weihong Niu, Yanwei Luo, Xinye Wang, Yao Zhou, Hui Li, Heran Wang, Yaojie Fu, Shanshan Liu, Shanghelin Yin, Jianglei Li, Ran Zhao, Yukun Liu, Songqing Fan, Zheng Li, Wei Xiong, Xiaoling Li, Guiyuan Li, Caiping Ren, Ming Tan, Ming Zhou
Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. Cell death & disease 10 (9) (2019)
Weihong Niu, Yanwei Luo, Xinye Wang, Yao Zhou, Hui Li, Heran Wang, Yaojie Fu, Shanshan Liu, Shanghelin Yin, Jianglei Li, Ran Zhao, Yukun Liu, Songqing Fan, Zheng Li, Wei Xiong, Xiaoling Li, Guiyuan Li, Caiping Ren, Ming Tan, Ming Zhou
BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. Cell death & disease 9 (5) (2018)
Zixing Liu, Wenling Zhang, Joshua B Phillips, Ritu Arora, Steven McClellan, Jiangfeng Li, Jin-Hwan Kim, Robert William Sobol, Ming Tan
Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene 38 (1) (2018)

Ming Tan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ming Tan